12:00 AM
Jun 05, 2000
 |  BC Week In Review  |  Company News  |  Deals

Fusion deal

FSON received U.S. Patent No. 6,066,325 covering fragmented hydrogels such as those used in FSON's...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >